title: PDGF-alpha and PDGF-beta are expressed in endometrial stromal sarcoma: a potential therapeutic target for tyrosine kinase inhibitors?
authors.forename: B
authors.initials: B
authors.lastname: Liegl
authors.forename: O
authors.initials: O
authors.lastname: Reich
authors.forename: F F
authors.initials: FF
authors.lastname: Nogales
authors.forename: S
authors.initials: S
authors.lastname: Regauer
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D002452:Cell Count; D016889:Endometrial Neoplasms / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D020574:Proto-Oncogene Proteins c-sis / Q000378:metabolism*; D018203:Sarcoma, Endometrial Stromal / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology
chemical_list: D014408:Biomarkers, Tumor; D004791:Enzyme Inhibitors; D010982:Platelet-Derived Growth Factor; D020574:Proto-Oncogene Proteins c-sis; C075278:platelet-derived growth factor A; D011505:Protein-Tyrosine Kinases